Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Neuroreport|November 13, 2004
Neuregulin genotype and medication response in Finnish patients with schizophreniaOlli Kampman, Sami Anttila, Ari Illi, et al.
Psychiatry Research|November 22, 2005
Changes in plasma amino acids after electroconvulsive therapy of depressed patientsJohanna Palmio, Martti Huuhka, Pirjo Saransaari, et al.
Psychiatric Genetics|June 5, 2003
NOTCH4 gene promoter polymorphism is associated with the age of onset in schizophreniaSami Anttila, Olli Kampman, Ari Illi, et al.
Acta Neuropsychiatrica|September 4, 2023
Genetic risk scores associated with temperament clusters in Finnish depression patientsSimo-Pekko Salminen, Anssi Solismaa, Leo-Pekka Lyytikäinen, et al.
Brain and Behavior|April 20, 2018
Low tumor necrosis factor-α levels predict symptom reduction during electroconvulsive therapy in major depressive disorderAnnamari Sorri, Kaija Järventausta, Olli Kampman, et al.
Brain and Behavior|October 2, 2018
Effect of electroconvulsive therapy on brain-derived neurotrophic factor levels in patients with major depressive disorderAnnamari Sorri, Kaija Järventausta, Olli Kampman, et al.
Alcohol (Fayetteville, N.Y.)|February 16, 2019
Status of inflammation and alcohol use in a 6-month follow-up study of patients with major depressive disorderMari Archer, Onni Niemelä, Kaisa Luoto, et al.
Brain and Behavior|August 3, 2021
Electroconvulsive therapy increases temporarily plasma vascular endothelial growth factor in patients with major depressive disorderAnnamari Sorri, Kaija Järventausta, Olli Kampman, et al.
Neuroscience Letters|July 12, 2011
Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDDMerja Viikki, Kaija Huuhka, Esa Leinonen, et al.
BMC Psychiatry|April 20, 2013
TPH1 A218C polymorphism and temperament in major depressionKadri Andre, Olli Kampman, Merja Viikki, et al.
Pageof 10